SCHEMBL30730414

SCHEMBL30730414

NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CALCRL Q16602 3/20 0.38
▸ OPRM1 P35372 1/20 0.38
▸ ITGB1 P05556 1/20 0.37
▸ ITGA4 P13612 1/20 0.37
▸ XIAP P98170 1/20 0.37
▸ DPP4 P27487 1/20 0.37
▸ PREP P48147 1/20 0.37
▸ FAP Q12884 1/20 0.37
▸ DPP8 Q6V1X1 1/20 0.37
▸ DPP9 Q86TI2 1/20 0.37
▸ F2 P00734 2/20 0.37
▸ REN P00797 1/20 0.37
▸ ACE P12821 1/20 0.37
▸ NTMT1 Q9BV86 2/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ RAMP1 O60894 1/20 0.37
▸ TACR1 P25103 1/20 0.36
▸ ITGB3 P05106 1/20 0.36
▸ ITGA2B P08514 1/20 0.36
▸ CMA1 P23946 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30493192 0.93 ITGB1 (0.36) CALCRLITGB1ITGA4XIAPDPP4
SCHEMBL29832504 0.92 CALCRL (0.41) CALCRLOPRM1ITGB1ITGA4XIAP
SCHEMBL31031470 0.91 CAPN1 (0.38) OPRM1ITGB1ITGA4DPP4PREP
SCHEMBL29414077 0.90 ITGB1 (0.35) CALCRLITGB1ITGA4XIAPDPP4
SCHEMBL29816594 0.90 PTGS1 (0.41) ITGB1ITGA4DPP4PREPFAP
SCHEMBL29833305 0.89 CALCRL (0.41) CALCRLOPRM1ITGB1ITGA4XIAP
SCHEMBL30138992 0.89 CAPN1 (0.40) OPRM1ITGB1ITGA4DPP4PREP
SCHEMBL29699495 0.88 KMT2A (0.43) ITGB1ITGA4XIAPRENKMT2A
SCHEMBL4258292 0.87 F2 (0.39) ITGB1ITGA4F2ACENTMT1
SCHEMBL29816717 0.87 NTMT1 (0.50) OPRM1ITGB1ITGA4F2ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12257323-B2 Modified wound dressings CONVATEC TECHNOLOGIES INC. (US) 2025-03-25 — — US disclosed
US-20240123091-A1 MODIFIED WOUND DRESSINGS CONVATEC TECHNOLOGIES, INC. 2024-04-18 — — US disclosed
US-11865192-B2 Modified wound dressings CONVATEC TECHNOLOGIES, INC. (US) 2024-01-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240123091-A1 MODIFIED WOUND DRESSINGS MMP8, CD68, ELANE CALCRL 2230/4885OPRM1 3161/4885ITGB1 1241/4885
US-11865192-B2 Modified wound dressings MMP8, CD68, ELANE CALCRL 2230/4885OPRM1 3161/4885ITGB1 1241/4885
US-12257323-B2 Modified wound dressings MMP8, CD68, ELANE CALCRL 2230/4885OPRM1 3161/4885ITGB1 1241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback